BioNTech said it will develop production facilities for its tuberculosis and malaria vaccines in Rwanda and Senegal. The vaccines will use messenger RNA technology, according to the company. The sites will be located near the World Health Organization's planned vaccine hubs.
Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.